These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12145447)

  • 1. Sensitization methodology and primary prevention of the research institute for fragrance materials.
    Api AM
    Dermatology; 2002; 205(1):84-7. PubMed ID: 12145447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the dermal sensitization Quantitative Risk Assessment (QRA) for fragrance ingredients.
    Api AM; Vey M
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):53-61. PubMed ID: 18635300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients.
    Api AM; Basketter DA; Cadby PA; Cano MF; Ellis G; Gerberick GF; Griem P; McNamee PM; Ryan CA; Safford R
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):3-23. PubMed ID: 18406028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Research Institute for Fragrance Materials' human repeated insult patch test protocol.
    Politano VT; Api AM
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):35-8. PubMed ID: 18177987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol and diethyl phthalate: vehicle effects in the local lymph node assay.
    Lalko J; Isola D; Api AM
    Int J Toxicol; 2004; 23(3):171-7. PubMed ID: 15204720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citral: identifying a threshold for induction of dermal sensitization.
    Lalko J; Api AM
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):62-73. PubMed ID: 18353514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for testing irritancy, allergy, and photoreactivity in fragrance safety evaluations.
    Hanifin JM; Api AM; Bickers DR
    Am J Contact Dermat; 2003 Jun; 14(2):100-3. PubMed ID: 14749031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragrance Skin Sensitization Evaluation and Human Testing: 30-Year Experience.
    Na M; Ritacco G; O'Brien D; Lavelle M; Api AM; Basketter D
    Dermatitis; 2021 Sep-Oct 01; 32(5):339-352. PubMed ID: 33093296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic contact dermatitis to fragrance: a review.
    Scheinman PL
    Am J Contact Dermat; 1996 Jun; 7(2):65-76. PubMed ID: 8796745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of contact dermatitis: prevalence of sensitization to different allergens and associated factors].
    Bordel-Gómez MT; Miranda-Romero A; Castrodeza-Sanz J
    Actas Dermosifiliogr; 2010; 101(1):59-75. PubMed ID: 20109394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal safety assessment of Arm & Hammer laundry products formulated for sensitive skin.
    Frederick DM; Vorwerk L; Gupta A; Ghassemi A
    Cutan Ocul Toxicol; 2017 Sep; 36(3):263-272. PubMed ID: 28073339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study to support a threshold of sensitization concern concept in risk assessment based on human data.
    Keller D; Krauledat M; Scheel J
    Arch Toxicol; 2009 Dec; 83(12):1049-60. PubMed ID: 19680631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contact allergy to fragrances].
    Kieć-Swierczyńska M; Krecisz B; Swierczyńska-Machura D
    Med Pr; 2006; 57(5):431-7. PubMed ID: 17340985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragrance series testing in eyelid dermatitis.
    Wenk KS; Ehrlich A
    Dermatitis; 2012; 23(1):22-6. PubMed ID: 22653065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragrance allergy: assessing the risk from washed fabrics.
    Corea NV; Basketter DA; Clapp C; Van Asten A; Marty JP; Pons-Guiraud A; Laverdet C
    Contact Dermatitis; 2006 Jul; 55(1):48-53. PubMed ID: 16842555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volatility of fragrance chemicals: patch testing implications.
    Gilpin SJ; Hui X; Maibach HI
    Dermatitis; 2009; 20(4):200-7. PubMed ID: 19804696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for the Research Institute for Fragrance Materials, Inc. (RIFM) safety evaluation process for fragrance ingredients.
    Api AM; Belsito D; Bruze M; Cadby P; Calow P; Dagli ML; Dekant W; Ellis G; Fryer AD; Fukayama M; Griem P; Hickey C; Kromidas L; Lalko JF; Liebler DC; Miyachi Y; Politano VT; Renskers K; Ritacco G; Salvito D; Schultz TW; Sipes IG; Smith B; Vitale D; Wilcox DK
    Food Chem Toxicol; 2015 Aug; 82 Suppl():S1-S19. PubMed ID: 25510979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A link between skin and airways regarding sensitivity to fragrance products?
    Elberling J; Linneberg A; Mosbech H; Dirksen A; Frølund L; Madsen F; Nielsen NH; Johansen JD
    Br J Dermatol; 2004 Dec; 151(6):1197-203. PubMed ID: 15606515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch test concentrations (doses in mg/cm2 ) for the 12 non-mix fragrance substances regulated by European legislation.
    Bruze M; Svedman C; Andersen KE; Bruynzeel D; Goossens A; Johansen JD; Matura M; Orton D; Vigan M;
    Contact Dermatitis; 2012 Mar; 66(3):131-6. PubMed ID: 22320667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.